Effective general practice: audit and feedback for the primary series of immunisations.

Introduction: General practice immunisation audits do not always match the national rates recorded on the New Zealand (NZ) National Immunisation Register (NIR).

Aim: To complete audits at one general practice for infants requiring the primary series of immunisations (6-week, 3-month and 5-month vaccines) over a 12-month period and compare findings with the NIR audit.

Methods: A manual and electronic practice management system (PMS) audit were compared with identical NIR audit parameters for completion of the 5-month vaccination from 1 February 2011 to 1 February 2012.

An investigation of three injections techniques in reducing local injection pain with a human papillomavirus vaccine: a randomized trial.

Background: Previous research suggests vaccine injection technique can influence local reactogenicity.

Objective: To identify characteristics of vaccination technique and individual vaccinees associated with frequency and severity of pain on injection and local reactogenicity following immunisation with quadrivalent human papillomavirus vaccine.

Design: Randomised cross-over trial of three injection techniques.

Human papillomavirus vaccination in Auckland: reducing ethnic and socioeconomic inequities.

Background: The New Zealand HPV publicly funded immunisation programme commenced in September 2008. Delivery through a school based programme was anticipated to result in higher coverage rates and reduced inequalities compared to vaccination delivered through other settings. The programme provided for on-going vaccination of girls in year 8 with an initial catch-up programme through general practices for young women born after 1 January 1990 until the end of 2010.

Early connections: effectiveness of a pre-call intervention to improve immunisation coverage and timeliness.

Introduction: Children who have missed or delayed immunisations are at greater risk of vaccine-preventable diseases and getting their first scheduled dose on time strongly predicts subsequent complete immunisation. Developing a relationship with an infant's parents and general practice staff soon after birth followed by a systematic approach can reduce the number of delayed first immunisations.

Aim: To assess the effectiveness of a general practice-based pre-call intervention to improve immunisation timeliness.

Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: the importance of routine active safety surveillance.

Objective: To evaluate and compare rates of febrile events, including febrile convulsion, following immunisation with four brands of inactivated 2010 and 2011 influenza vaccine in NZ infants and children.

Design: Retrospective telephone surveys of parents of infants and children who received at least one dose of the vaccines of interest.

Setting: 184 NZ General Practices who received the vaccines of interest.

Fever following administration of two inactivated influenza vaccines--a survey of parents of New Zealand infants and children 5 years of age and under.

Unlabelled: Due to a dramatic increase in reported febrile convulsions in Western Australia following a routine pediatric influenza vaccination programme we evaluated parental recall of fever in their child following 2010 trivalent influenza vaccine manufactured by either Sanofi Pasteur (Vaxigrip(®)) or CSL Biotherapies (Fluvax(®)) to determine if the rates of febrile events in infants and children 5 years and under following administration of either Vaxigrip(®) or Fluvax(®) were significantly different.

Method: A convenience sample of New Zealand General practices who had received stocks of the vaccines of interest consecutively contacted parents of infants and children under 5 years of age who received at least one dose of 2010 influenza vaccine. A brief questionnaire was administered with the main outcome parental recall of fever within 24 h of vaccination.